CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 54 filers reported holding CASI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | 0.0% | 10,002 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -33.3% | 10,002 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -25.0% | 10,002 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -33.3% | 10,002 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | -20.0% | 10,002 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $30,000 | +100.0% | 10,002 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | -40.0% | 10,002 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $25,000 | +25.0% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $20,000 | -35.5% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $31,000 | -6.1% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $33,000 | +3.1% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $32,000 | +10.3% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $29,000 | -27.5% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $40,000 | -14.9% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $47,000 | -42.7% | 10,002 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $82,000 | +95.2% | 10,002 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $42,000 | +27.3% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $33,000 | +83.3% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $18,000 | +63.6% | 10,002 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -21.4% | 10,002 | 0.0% | 0.00% | – |
| Q1 2017 | $14,000 | +16.7% | 10,002 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | +9.1% | 10,002 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -8.3% | 10,002 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | +9.1% | 10,002 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | +10.0% | 10,002 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -9.1% | 10,002 | 0.0% | 0.00% | – |
| Q3 2015 | $11,000 | -38.9% | 10,002 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $18,000 | +20.0% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $15,000 | +15.4% | 10,002 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | -27.8% | 10,002 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $18,000 | 0.0% | 10,002 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $18,000 | – | 10,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |